Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2025-12-25 @ 11:30 PM
NCT ID: NCT02573493
Term: Fatigue
Organ System: General disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE (3.0)
Notes: None
Study: NCT02573493
Study Brief: Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 24 40 View
EG001 None 21 40 View
EG002 None 10 15 View
EG003 None 29 34 View
EG004 None 26 42 View
EG005 None 13 15 View
EG006 None None 0 View
EG007 None None 0 View
EG008 None None 0 View